Literature DB >> 18636529

Haplotype associations with quantitative traits in the presence of complex multilocus and heterogeneous effects.

Kyoko Shibata1, Luda Diatchenko, Dmitri V Zaykin.   

Abstract

In genetic mapping of complex traits, scored haplotypes are likely to represent only a subset of all causal polymorphisms. At the extreme of this scenario, observed polymorphisms are not themselves functional, and only linked to causal ones via linkage disequilibrium (LD). We will demonstrate that due to such incomplete knowledge regarding the underlying genetic mechanism, the variance of a trait may become different between the scored haplotypes. Thus, unequal variances between haplotypes may be indicative of additional functional polymorphisms affecting the trait. Methods accounting for such haplotype-specific variance may also provide an increased power to detect complex associations. We suggest ways to estimate and test these haplotypic variance contrasts, and incorporate them into the haplotypic tests for association. We further extend this approach to data with unknown gametic phase via likelihood-based simultaneous estimation of haplotypic effects and their frequencies. We find our approach to provide additional power, especially under the following types of models: (a) where scored and unobserved variants are epistatically interacting with each other; and (b) under heterogeneity models, where multiple unobserved mutations are linked to non-functional observed polymorphisms via LD. An illustrative example of usefulness of the method is discussed, utilizing analysis of multilocus effects within the catechol-O-methyltransferase gene.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18636529      PMCID: PMC2700858          DOI: 10.1002/gepi.20358

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  45 in total

1.  Inference on haplotype effects in case-control studies using unphased genotype data.

Authors:  Michael P Epstein; Glen A Satten
Journal:  Am J Hum Genet       Date:  2003-11-20       Impact factor: 11.025

2.  Simultaneous estimation of haplotype frequencies and quantitative trait parameters: applications to the test of association between phenotype and diplotype configuration.

Authors:  Kyoko Shibata; Toshikazu Ito; Yutaka Kitamura; Naoko Iwasaki; Hiroshi Tanaka; Naoyuki Kamatani
Journal:  Genetics       Date:  2004-09       Impact factor: 4.562

3.  Genetic flip-flop without an accompanying change in linkage disequilibrium.

Authors:  Dmitri V Zaykin; Kyoko Shibata
Journal:  Am J Hum Genet       Date:  2008-03       Impact factor: 11.025

4.  A highly significant association between a COMT haplotype and schizophrenia.

Authors:  Sagiv Shifman; Michal Bronstein; Meira Sternfeld; Anne Pisanté-Shalom; Efrat Lev-Lehman; Avraham Weizman; Ilya Reznik; Baruch Spivak; Nimrod Grisaru; Leon Karp; Richard Schiffer; Moshe Kotler; Rael D Strous; Marnina Swartz-Vanetik; Haim Y Knobler; Eilat Shinar; Jacques S Beckmann; Benjamin Yakir; Neil Risch; Naomi B Zak; Ariel Darvasi
Journal:  Am J Hum Genet       Date:  2002-10-25       Impact factor: 11.025

5.  Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli.

Authors:  Luda Diatchenko; Andrea G Nackley; Gary D Slade; Kanokporn Bhalang; Inna Belfer; Mitchell B Max; David Goldman; William Maixner
Journal:  Pain       Date:  2006-07-11       Impact factor: 6.961

Review 6.  Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors.

Authors:  P T Männistö; S Kaakkola
Journal:  Pharmacol Rev       Date:  1999-12       Impact factor: 25.468

7.  Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder.

Authors:  M Karayiorgou; C Sobin; M L Blundell; B L Galke; L Malinova; P Goldberg; J Ott; J A Gogos
Journal:  Biol Psychiatry       Date:  1999-05-01       Impact factor: 13.382

8.  A simple and improved correction for population stratification in case-control studies.

Authors:  Michael P Epstein; Andrew S Allen; Glen A Satten
Journal:  Am J Hum Genet       Date:  2007-03-29       Impact factor: 11.025

9.  Combining p-values in large-scale genomics experiments.

Authors:  Dmitri V Zaykin; Lev A Zhivotovsky; Wendy Czika; Susan Shao; Russell D Wolfinger
Journal:  Pharm Stat       Date:  2007 Jul-Sep       Impact factor: 1.894

10.  Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors.

Authors:  Andrea Gail Nackley; Kai Soo Tan; Karamarie Fecho; Patrick Flood; Luda Diatchenko; William Maixner
Journal:  Pain       Date:  2006-11-07       Impact factor: 7.926

View more
  10 in total

1.  Potential genetic risk factors for chronic TMD: genetic associations from the OPPERA case control study.

Authors:  Shad B Smith; Dylan W Maixner; Joel D Greenspan; Ronald Dubner; Roger B Fillingim; Richard Ohrbach; Charles Knott; Gary D Slade; Eric Bair; Dustin G Gibson; Dmitri V Zaykin; Bruce S Weir; William Maixner; Luda Diatchenko
Journal:  J Pain       Date:  2011-11       Impact factor: 5.820

2.  A study in scarlet: MC1R as the main predictor of red hair and exemplar of the flip-flop effect.

Authors:  Katerina Zorina-Lichtenwalter; Ryan N Lichtenwalter; Dima V Zaykin; Marc Parisien; Simon Gravel; Andrey Bortsov; Luda Diatchenko
Journal:  Hum Mol Genet       Date:  2019-06-15       Impact factor: 6.150

3.  Pain modality- and sex-specific effects of COMT genetic functional variants.

Authors:  Inna Belfer; Samantha K Segall; William R Lariviere; Shad B Smith; Feng Dai; Gary D Slade; Naim U Rashid; Jeffrey S Mogil; Claudia M Campbell; Robert R Edwards; Qian Liu; Eric Bair; William Maixner; Luda Diatchenko
Journal:  Pain       Date:  2013-04-17       Impact factor: 6.961

4.  Complex multilocus effects of catechol-O-methyltransferase haplotypes predict pain and pain interference 6 weeks after motor vehicle collision.

Authors:  Andrey V Bortsov; Luda Diatchenko; Samuel A McLean
Journal:  Neuromolecular Med       Date:  2013-08-21       Impact factor: 3.843

5.  Catechol-O-methyltransferase genotype predicts pain severity in hospitalized burn patients.

Authors:  Danielle C Orrey; Andrey V Bortsov; Janelle M Hoskins; Jeffrey W Shupp; Samuel W Jones; Bryan J Cicuto; James Hwang; Marion H Jordan; James H Holmes; Linwood R Haith; Brandon M Roane; Luda Diatchenko; Bruce A Cairns; Samuel A McLean
Journal:  J Burn Care Res       Date:  2012 Jul-Aug       Impact factor: 1.845

6.  A low COMT activity haplotype is associated with recurrent preeclampsia in a Norwegian population cohort (HUNT2).

Authors:  L T Roten; M H Fenstad; S Forsmo; M P Johnson; E K Moses; R Austgulen; F Skorpen
Journal:  Mol Hum Reprod       Date:  2011-02-25       Impact factor: 4.025

7.  Low enzymatic activity haplotypes of the human catechol-O-methyltransferase gene: enrichment for marker SNPs.

Authors:  Andrea G Nackley; Svetlana A Shabalina; Jason E Lambert; Mathew S Conrad; Dustin G Gibson; Alexey N Spiridonov; Sarah K Satterfield; Luda Diatchenko
Journal:  PLoS One       Date:  2009-04-13       Impact factor: 3.240

8.  Expansion of the human mu-opioid receptor gene architecture: novel functional variants.

Authors:  Svetlana A Shabalina; Dmitri V Zaykin; Pavel Gris; Aleksey Y Ogurtsov; Josee Gauthier; Kyoko Shibata; Inna E Tchivileva; Inna Belfer; Bikashkumar Mishra; Carly Kiselycznyk; Margaret R Wallace; Roland Staud; Nikolay A Spiridonov; Mitchell B Max; David Goldman; Roger B Fillingim; William Maixner; Luda Diatchenko
Journal:  Hum Mol Genet       Date:  2008-12-22       Impact factor: 6.150

9.  Novel approach identifies SNPs in SLC2A10 and KCNK9 with evidence for parent-of-origin effect on body mass index.

Authors:  Clive J Hoggart; Giulia Venturini; Massimo Mangino; Felicia Gomez; Giulia Ascari; Jing Hua Zhao; Alexander Teumer; Thomas W Winkler; Natalia Tšernikova; Jian'an Luan; Evelin Mihailov; Georg B Ehret; Weihua Zhang; David Lamparter; Tõnu Esko; Aurelien Macé; Sina Rüeger; Pierre-Yves Bochud; Matteo Barcella; Yves Dauvilliers; Beben Benyamin; David M Evans; Caroline Hayward; Mary F Lopez; Lude Franke; Alessia Russo; Iris M Heid; Erika Salvi; Sailaja Vendantam; Dan E Arking; Eric Boerwinkle; John C Chambers; Giovanni Fiorito; Harald Grallert; Simonetta Guarrera; Georg Homuth; Jennifer E Huffman; David Porteous; Darius Moradpour; Alex Iranzo; Johannes Hebebrand; John P Kemp; Gert J Lammers; Vincent Aubert; Markus H Heim; Nicholas G Martin; Grant W Montgomery; Rosa Peraita-Adrados; Joan Santamaria; Francesco Negro; Carsten O Schmidt; Robert A Scott; Tim D Spector; Konstantin Strauch; Henry Völzke; Nicholas J Wareham; Wei Yuan; Jordana T Bell; Aravinda Chakravarti; Jaspal S Kooner; Annette Peters; Giuseppe Matullo; Henri Wallaschofski; John B Whitfield; Fred Paccaud; Peter Vollenweider; Sven Bergmann; Jacques S Beckmann; Mehdi Tafti; Nicholas D Hastie; Daniele Cusi; Murielle Bochud; Timothy M Frayling; Andres Metspalu; Marjo-Riitta Jarvelin; André Scherag; George Davey Smith; Ingrid B Borecki; Valentin Rousson; Joel N Hirschhorn; Carlo Rivolta; Ruth J F Loos; Zoltán Kutalik
Journal:  PLoS Genet       Date:  2014-07-31       Impact factor: 5.917

10.  COMT gene locus: new functional variants.

Authors:  Carolina B Meloto; Samantha K Segall; Shad Smith; Marc Parisien; Svetlana A Shabalina; Célia M Rizzatti-Barbosa; Josée Gauthier; Douglas Tsao; Marino Convertino; Marjo H Piltonen; Gary Dmitri Slade; Roger B Fillingim; Joel D Greenspan; Richard Ohrbach; Charles Knott; William Maixner; Dmitri Zaykin; Nikolay V Dokholyan; Ilkka Reenilä; Pekka T Männistö; Luda Diatchenko
Journal:  Pain       Date:  2015-10       Impact factor: 7.926

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.